Demographic, clinic, and genetic characteristics in 149 children diagnosed with familial mediterranean fever

Familial Mediterranean fever (FMF) is a hereditary disease characterized by recurrent attacks of fever, peritonitis, pleuritis and/or synovitis. In this study, we retrospectively evaluated demographic, clinical findings, and genetic features in 149 children (63 male/86 female) with FMF. The mean age of the patients at the time of diagnosis was 6.44 ± 3.21 years. A positive family history for FMF was present in 26%, and 8% of the patients had consanguinity between the parents. The frequency of family history of FMF was found to be higher in patients diagnosed under 10 years of age (p=0.038). Frequencies of the most frequent symptoms observed in cases during episodes were abdominal pain (95%), fever (68%), and arthralgia/arthritis (23%). Genetic analysis revealed that 16% of the patients had homozygous mutations, 32% had heterozygous mutations, and 38% had compound heterozygous mutations, while no mutations were detected in 21 (14%). There were mutant genes in 218 alleles, the most frequently observed were R202Q (48%), M694V (24%), and E148Q (17%). Patients with non-R202Q compound heterozygous mutation had higher frequency of high fever, CRP (C-reactive protein) levels, and fibrinogen levels during the episodes (p=0.006, p=0.001, and p=0.042, respectively). Thus, our study showed that R202Q mutation appeared to have no significant disease-causing and clinical effects, while mutations at exon 10 were associated with increased severity of symptoms as well as elevated levels of acute phase reactants. Further studies with larger FMF populations may shed more light on the role of these mutations in the pathogenesis of FMF.

[1]  N. Duru,et al.  Relationship Among Clinical, Laboratory Findings, Disease Severity Scores and Genetic Mutations in Patient with Familial Mediterranean Fever , 2018 .

[2]  A. Duzova,et al.  Familial Mediterranean fever with a single MEFV mutation: comparison of rare and common mutations in a Turkish paediatric cohort. , 2015, Clinical and experimental rheumatology.

[3]  E. Bora,et al.  Clinical Significance of R202Q Alteration of MEFV Gene in Children With Familial Mediterranean Fever , 2015 .

[4]  B. Kısacık,et al.  Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. , 2012, Gene.

[5]  R. Shawky,et al.  Hereditary periodic fever syndromes , 2011 .

[6]  U. Erkorkmaz,et al.  Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype–phenotype correlation in children , 2009, Journal of paediatrics and child health.

[7]  N. Akar,et al.  Is MEFVGene Arg202Gln (605 G>A) A Disease-Causing Mutation? , 2008 .

[8]  M. Doumas,et al.  MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever , 2007, Clinical genetics.

[9]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[10]  A. Bakkaloğlu,et al.  Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study , 2005, Medicine.

[11]  C. Cazeneuve,et al.  Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. , 2003, Clinical chemistry.

[12]  A. Bakkaloğlu,et al.  Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. , 2003, Clinical and experimental rheumatology.

[13]  A. Bakkaloğlu,et al.  Pyrin Q148 mutation and familial Mediterranean fever. , 2002, QJM : monthly journal of the Association of Physicians.

[14]  M. Arıcı,et al.  Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. , 1998, Clinical and experimental rheumatology.

[15]  D. Zemer,et al.  The changing face of familial Mediterranean fever. , 1996, Seminars in arthritis and rheumatism.

[16]  E. Sohar,et al.  FAMILIAL MEDITERRANEAN FEVER , 1959, Definitions.

[17]  E. Sohar,et al.  Familial Mediterranean fever. , 1955, Klinische Padiatrie.

[18]  O. Kasapcopur,et al.  Familial Mediterranean fever in childhood: a single-center experience , 2017, Rheumatology International.

[19]  F. Ozkinay,et al.  MEFV mutations in patients with familial Mediterranean fever from the Aegean region of Turkey , 2009, Molecular Biology Reports.

[20]  A. Cercek,et al.  Assessment of pyrin gene mutations in Turks with familial Mediterranean fever (FMF) , 1998, Human mutation.